Austedo

Product manufactured by Teva Neuroscience, Inc.

Application Nr Approved Date Route Status External Links
NDA208082 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Austedo ® Is Indicated For The Treatment Of: Chorea Associated With Huntington’s Disease [See Clinical Studies (14.1)] Tardive Dyskinesia In Adults [See Clinical Studies (14.2)] Austedo Is A Vesicular Monoamine Transporter 2 (Vmat2) Inhibitor Indicated For The Treatment Of: Chorea Associated With Huntington’s Disease ( 1 ) Tardive Dyskinesia In Adults ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Deutetrabenazine

Comments